Delivery Order SPE2DB22D1017-SPE2DB25FG3BE

Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,349.84, is a delivery order for the supply of 4,568,105,478 units of Terbinafine HCL 250 mg tablets. The contract is a firm fixed-price, non-set-aside award with a completion date of May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $8,773.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,187,358 units of the prescription medication Terbinafine HCL 250 mg tablets, with a final completion date of May 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside contract....
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency, a defense agency, for the supply of 90 tablets of the medication Terbinafine HCL 250 mg. The contract has a ceiling value of $5,181.95 and a period of performance ending on May 19, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a $999,999,999 Indefinite...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVL96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,837.26 firm fixed-price delivery order is for the supply of 4,568,078,153 units of the prescription medication terbinafine hydrochloride 250 mg tablets. The contract has an ultimate completion date of April 30, 2025 and was awarded on April 29, 2025. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,838.53 firm fixed-price delivery order contract has an ultimate completion date of April 22, 2025. The contract is not set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,838.53 firm fixed price delivery order contract has a completion date of May 13, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor and this award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) the company holds with the DLA...
This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) to provide 4,568,056,484 units of Terbinafine HCL 250 mg tablets. The contract has a ceiling value of $21,820.64 and a period of performance through April 29, 2025. This contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite...
This federal contract award, valued at $25,534.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price, and an ultimate completion date of May 6, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,640.27 Firm Fixed Price Delivery Order contract has an ultimate completion date of May 9, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of TERBINAFINE HCL 250 MG TABLET 100S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $5,031.55 and an ultimate completion date of May 13, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG3BE
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,413.64 Firm Fixed Price delivery order is for the supply of 100 tablets of the pharmaceutical product Terbinafine Hydrochloride 250 mg. The contract has an ultimate completion date of May 21, 2025.

Amerisourcebergen Drug Corp also holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

The contract award is not designated as a set-aside, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, with a particular focus on delivering a comprehensive range of products to the Defense Health Agency, U.S. Coast Guard, and other government customers.

Generated 8/24/25, 12:43 AM